Latest AI and machine learning research in bph/luts for healthcare professionals.
Current diagnostic tests for lower urinary tract symptoms (LUTS) do not assess tissue-level alterations in the bladder wall. This study assesses the feasibility of 3D magnetic resonance fingerprinting (MRF) for simultaneous T1, T2, and proton density (M0) mapping of the bladder wall in healthy subjects at 1.5 T and 3 T. A 3D MRF acquisition was combined with a deep image prior reconstruction to ac...
Prostate cancer (PCa) is the most commonly diagnosed noncutaneous malignancy in men and a leading cause of cancer-related death worldwide. Its clinical heterogeneity, ranging from indolent to aggressive disease, presents major diagnostic and therapeutic challenges. However, prostate-specific antigen (PSA), the current standard biomarker, lacks sufficient sensitivity and specificity, resulting in b...
BACKGROUND: The frailty index (FI) is a well-established marker of biological aging and a widely validated predictor of adverse health outcomes in old...
Prostatic artery embolization (PAE) is a safe and effective minimally invasive treatment for lower urinary tract symptoms (LUTS) attributed to benign ...
The paper deals with an application of machine learning algorithms to examine the impact of agricultural land-use types on CO₂ emissions in Vietnam du...
BACKGROUND: Prostate cancer (PCa) is characterized by pronounced intratumoral heterogeneity and multifocality, presenting ongoing challenges for early...
Urinary extracellular vesicles (uEVs) are promising biomarkers for prostate cancer (PCa). Although novel uEV-based biomarkers have advanced early diag...
Benign prostatic hyperplasia (BPH) is a prevalent age-related disorder characterized by chronic inflammation, metabolic dysregulation, and abnormal ce...
This study investigates the identification of Benign Prostatic Hyperplasia (BPH) through a deep learning-based analysis of RGB prostate histopathologi...
Paper spray ionization mass spectrometry (PSI-MS)-based nontargeted metabolomics was employed to rapidly classify prostate health conditions using uri...
INTRODUCTION AND HYPOTHESIS: Chronic lower urinary tract symptoms (LUTS) are characterised by persistent symptoms and elevated urinary leukocyte count...
This narrative review explores the complex relationship between lower urinary tract symptoms (LUTS) and mental health disorders, focusing on the influ...
The non-invasive diagnosis and risk stratification of prostate cancer (PCa) remain clinically challenging due to the limited specificity of prostate-s...
BACKGROUND: Oxidative stress (OS) is increasingly implicated in benign prostatic hyperplasia (BPH), yet the underlying cellular programs remain unclea...
PURPOSE: To evaluate the performance of ChatGPT-4o in estimating International Prostate Symptom Score (IPSS) and Overactive Bladder Symptom Score (OAB...
BACKGROUND: Prostate cancer (PCa) is the most common solid organ cancer in men and the fifth leading cause of cancer-related deaths globally. PSA help...
BACKGROUND: AUA guidelines for shared decision making (SDM) in prostate cancer recommend discussion of five content areas in consultations: (1) cancer...
BACKGROUND: Machine learning (ML) and artificial intelligence (AI) have demonstrated powerful functionality in the healthcare setting thus far. We aim...
Introduction Assessing male lower urinary tract symptoms (LUTS) due to Benign outlet obstruction (BOO) remains a challenge in urology due to the limit...
INTRODUCTION: Population aging is increasing rapidly, representing a global trend that has launched many discussions regarding older adult's quality o...